Newron Pharmaceuticals SpA (NWRN) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Newron Pharmaceuticals SpA (NWRN) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of CHF33.32 Million represents 1% of operating cash flow (CHF33.35 Million). See NWRN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

CHF33.32 Million

CHF

Operating Cash Flow

CHF33.35 Million

CHF

Capital Expenditures

CHF31.00K

CHF

Newron Pharmaceuticals SpA Free Cash Flow Generation Index (2012–2025)

Historical FCF Generation Index trend for Newron Pharmaceuticals SpA across 2 annual periods. Explore how well can Newron Pharmaceuticals SpA service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Newron Pharmaceuticals SpA (2012–2025)

Year-by-year Free Cash Flow Generation Index for Newron Pharmaceuticals SpA. For the full company profile including market capitalisation, see Newron Pharmaceuticals SpA (NWRN) market capitalisation.

Year	FCG Index	Free Cash Flow (CHF)	Operating CF	Capital Expenditures	YoY Change
2025	1.00x	CHF32.51 Million	CHF32.56 Million	CHF47.30K	▲ +0.0%
2012	1.00x	CHF5.81 Million	CHF5.83 Million	CHF11.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).